CY1201A - Substituted orthoanisamides methods of preparing them compositions containing them and their application as psychotropic agents - Google Patents

Substituted orthoanisamides methods of preparing them compositions containing them and their application as psychotropic agents

Info

Publication number
CY1201A
CY1201A CY1201A CY120179A CY1201A CY 1201 A CY1201 A CY 1201A CY 1201 A CY1201 A CY 1201A CY 120179 A CY120179 A CY 120179A CY 1201 A CY1201 A CY 1201A
Authority
CY
Cyprus
Prior art keywords
orthoanisamides
substituted
preparing
methods
application
Prior art date
Application number
CY1201A
Other languages
English (en)
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ile De France filed Critical Ile De France
Publication of CY1201A publication Critical patent/CY1201A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
CY1201A 1978-01-20 1979-01-17 Substituted orthoanisamides methods of preparing them compositions containing them and their application as psychotropic agents CY1201A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7801632A FR2415099A1 (fr) 1978-01-20 1978-01-20 Nouveaux derives de 4-amino-5-alkylsulfonyl ortho-anisamides, leurs procedes de preparation et leur application comme psychotropes

Publications (1)

Publication Number Publication Date
CY1201A true CY1201A (en) 1983-12-31

Family

ID=9203689

Family Applications (1)

Application Number Title Priority Date Filing Date
CY1201A CY1201A (en) 1978-01-20 1979-01-17 Substituted orthoanisamides methods of preparing them compositions containing them and their application as psychotropic agents

Country Status (42)

Country Link
US (2) US4294828A (xx)
JP (1) JPS6049192B2 (xx)
AR (2) AR221354A1 (xx)
AT (1) AT377977B (xx)
AU (1) AU528561B2 (xx)
BE (1) BE872585A (xx)
BG (2) BG31497A3 (xx)
CA (1) CA1101430A (xx)
CH (1) CH637927A5 (xx)
CS (1) CS226181B2 (xx)
CY (1) CY1201A (xx)
DD (1) DD141520A5 (xx)
DE (1) DE2901181C2 (xx)
DK (1) DK158346C (xx)
EG (1) EG14045A (xx)
ES (2) ES476755A1 (xx)
FI (1) FI71126C (xx)
FR (1) FR2415099A1 (xx)
GB (2) GB2012765B (xx)
GR (1) GR64431B (xx)
HK (1) HK12184A (xx)
HU (1) HU179793B (xx)
IE (1) IE47798B1 (xx)
IL (1) IL56411A (xx)
IN (1) IN150226B (xx)
IT (1) IT1164655B (xx)
LU (1) LU80786A1 (xx)
MC (1) MC1232A1 (xx)
MX (2) MX7623E (xx)
NL (1) NL191707C (xx)
NO (1) NO151320C (xx)
NZ (1) NZ189378A (xx)
OA (1) OA06156A (xx)
PH (2) PH15725A (xx)
PL (2) PL116532B1 (xx)
PT (1) PT69068A (xx)
RO (2) RO76393A (xx)
SE (2) SE448874B (xx)
SU (1) SU820659A3 (xx)
YU (2) YU42172B (xx)
ZA (1) ZA79219B (xx)
ZM (1) ZM579A1 (xx)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2440946A2 (fr) * 1978-01-20 1980-06-06 Ile De France Nouveaux benzamides heterocycliques substitues, leurs procedes de preparation et leur application comme modificateurs du comportement
ZA818221B (en) * 1980-12-12 1982-10-27 Beecham Group Plc Pharmaceutical compounds
FR2550447B1 (fr) * 1983-08-10 1986-01-17 Ile De France Application du n-(ally-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide comme antiagregant plaquettaire
FR2574795B1 (fr) * 1984-12-18 1987-11-20 Ile De France Nouveau procede industriel de synthese du n-((1'-allyl 2'-pyrrolidinyl) methyl) 2-methoxy 4,5-azimido benzamide
FR2584401B1 (fr) * 1985-07-04 1987-11-20 Ile De France Nouveau benzamide, son procede de preparation et son application dans le domaine therapeutique
US5227388A (en) * 1989-12-26 1993-07-13 Hoechst-Roussel Pharmaceuticals Incorporated Thienobenzoxepins and naphthothiophenes
US5260319A (en) * 1989-12-26 1993-11-09 Hoechst-Roussel Pharmaceuticals Incorporated Thienobenzoxepins and naphthothiophenes
FR2678266A1 (fr) * 1991-06-28 1992-12-31 Delagrange Laboratoires Nouveaux derives de 2-hydroxy 4-amino 5-ethylsulfonyl benzamide utiles comme anxiolytiques.
FR2699533A1 (fr) * 1992-12-21 1994-06-24 Mouhtaram Mohamed Dérivés de N-((1,4-dialkyl-6-arylpipérazine-2-yl)méthyl)benzamides. (Isomères cis et trans) Propriétés pharmacologiques et applications.
FR2753376B1 (fr) * 1996-09-18 1998-10-16 Synthelabo Compositions pharmaceutiques comprenant de l'amisulpride et leurs applications therapeutiques
FR2762213B1 (fr) * 1997-04-18 1999-05-14 Synthelabo Composition pharmaceutique a retention gastrique
US6169094B1 (en) * 1998-07-14 2001-01-02 Sanofi-Synthelabo Compositions of (S) (-)-amisulpride
ATE445838T1 (de) 2001-07-25 2009-10-15 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
WO2004100992A2 (en) * 2003-05-16 2004-11-25 Pfizer Products Inc. Therapeutic combinations of atypical antipsychotics with gaba modulators, anticonvulsants or benzodiazapines
FR2857263B1 (fr) * 2003-07-09 2005-09-09 Sanofi Synthelabo Nouvelle composition pharmaceutique solide comprenant de l'amisulpride
WO2005107808A2 (en) * 2004-05-11 2005-11-17 Pfizer Products Inc. Combination of atypical antipsychotics and 5-ht1b receptor antagonists
AR056321A1 (es) * 2005-04-22 2007-10-03 Wyeth Corp COMBINACIONES TERAPÉUTICAS PARA EL TRATAMIENTO O LA PREVENCIoN DE TRASTORNOS PSICoTICOS
WO2006116718A2 (en) 2005-04-28 2006-11-02 Proteus Biomedical, Inc. Pharma-informatics system
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質（ｒａｐ）結合体の投与による肝障害の処置
US7825156B2 (en) * 2007-02-02 2010-11-02 Copharms Method of treating bipolar depression with a benzamide derivative
CA2727573A1 (en) * 2008-06-25 2009-12-30 Pfizer Inc. Diaryl compounds and uses thereof
US20100105755A1 (en) * 2008-09-12 2010-04-29 Auspex Pharmaceuticals, Inc. Substituted benzamide modulators of dopamine receptor
WO2010095940A2 (en) 2009-02-20 2010-08-26 To-Bbb Holding B.V. Glutathione-based drug delivery system
KR101741629B1 (ko) 2009-05-06 2017-05-31 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
CN101898991B (zh) * 2009-05-31 2013-09-25 江苏天士力帝益药业有限公司 一种(s)(-)-氨磺必利d-(-)-酒石酸盐的合成方法
CN101628886B (zh) * 2009-08-25 2012-12-12 北京紫萌同达科技有限公司 一种2-甲氧基-4-氨基-5-乙砜基苯甲酸的合成方法
GB201004020D0 (en) * 2010-03-11 2010-04-21 Acacia Pharma Ltd New therapeutic use
AU2016216578B2 (en) * 2010-03-11 2017-11-23 Acacia Pharma Limited The use of amisulpride as an anti-emetic
AU2014202535B2 (en) * 2010-03-11 2016-05-26 Acacia Pharma Limited The use of amisulpride as an anti-emetic
BR112012031959A2 (pt) 2010-06-17 2015-09-22 Lupin Ltd um processo aperfeiçoado para preparação de amisulpride
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN103304453A (zh) * 2013-06-18 2013-09-18 苏州诚和医药化学有限公司 两步法合成2-甲氧基-4-氨基-5-乙砜基苯甲酸
CN103319384A (zh) * 2013-06-18 2013-09-25 苏州诚和医药化学有限公司 制备2-甲氧基-4-氨基-5-乙砜基苯甲酸的方法
CN103450058B (zh) * 2013-09-18 2015-10-14 广安凯特医药化工有限公司 一种氨磺必利酸的制备方法
CN104725292B (zh) * 2015-03-23 2017-07-25 湖北荆江源制药股份有限公司 一种(s)(‑)‑氨磺必利的制备方法
GB201618425D0 (en) * 2016-11-01 2016-12-14 Acacia Pharma Ltd method
AU2017364899B2 (en) * 2016-11-28 2023-07-06 Lb Pharmaceuticals Inc. Psychotropic agents and uses thereof
US11377421B2 (en) 2016-11-28 2022-07-05 Lb Pharmaceuticals Inc. Psychotropic agents and uses thereof
CN106995397B (zh) * 2016-12-12 2020-01-14 河北医科大学 R-氨磺必利药用盐、制备方法、晶型及其用途
GB201702250D0 (en) 2017-02-10 2017-03-29 Acacia Pharma Ltd Method
CN118593482A (zh) 2017-12-05 2024-09-06 赛诺维信制药公司 非外消旋混合物及其用途
US10377708B2 (en) 2017-12-05 2019-08-13 Sunovion Pharmaceuticals Inc. Crystal forms and production methods thereof
CN110790693A (zh) * 2018-08-02 2020-02-14 北京万全德众医药生物技术有限公司 一种(s)(-)-氨磺必利的制备方法
BR112021024380A2 (pt) 2019-06-04 2022-04-19 Sunovion Pharmaceuticals Inc Formulações de liberação modificadas e usos das mesmas

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
FR2313935A1 (fr) * 1975-06-10 1977-01-07 Ile De France Nouveaux benzamides substitues, leurs derives et leur procede de preparation
US3862139A (en) * 1972-06-23 1975-01-21 Delmar Chem Heterocyclic benzamide compounds
FR2244760B1 (xx) * 1973-09-25 1980-06-27 Ile De France
FR2299862B1 (fr) * 1975-02-07 1978-07-21 Ile De France Nouveau
FR2294698A1 (fr) * 1974-12-18 1976-07-16 Synthelabo Nouveaux derives des methoxy-2 benzamides substitues, leurs sels, leur preparation et les medicaments qui en renferment
CA1039731A (en) * 1974-12-18 1978-10-03 Synthelabo Process for preparing new 2-methoxy-benzamide derivatives

Also Published As

Publication number Publication date
HK12184A (en) 1984-02-24
US4401822A (en) 1983-08-30
IL56411A (en) 1982-09-30
PH22287A (en) 1988-07-22
GB2083458B (en) 1983-03-09
IL56411A0 (en) 1979-03-12
GB2083458A (en) 1982-03-24
DE2901181C2 (de) 1984-07-19
FR2415099A1 (fr) 1979-08-17
EG14045A (en) 1983-09-30
FI71126B (fi) 1986-08-14
IE47798B1 (en) 1984-06-27
AT377977B (de) 1985-05-28
MX7623E (es) 1990-03-27
SE8603773L (sv) 1986-09-09
NO790180L (no) 1979-07-23
NO151320B (no) 1984-12-10
PL118151B1 (en) 1981-09-30
JPS6049192B2 (ja) 1985-10-31
YU25483A (en) 1983-10-31
SE460968B (sv) 1989-12-11
BG31497A3 (en) 1982-01-15
PL212899A1 (xx) 1980-01-14
DD141520A5 (de) 1980-05-07
PL116532B1 (en) 1981-06-30
AU528561B2 (en) 1983-05-05
PH15725A (en) 1983-03-18
JPS54145658A (en) 1979-11-14
MC1232A1 (fr) 1979-10-26
RO80311A (ro) 1982-12-06
YU42172B (en) 1988-06-30
ZA79219B (en) 1980-01-30
SE7900380L (sv) 1979-07-21
PT69068A (fr) 1979-02-01
ZM579A1 (en) 1979-12-21
OA06156A (fr) 1981-06-30
SE448874B (sv) 1987-03-23
ES476755A1 (es) 1979-06-01
LU80786A1 (fr) 1979-09-07
DK20979A (da) 1979-07-21
DK158346B (da) 1990-05-07
MX5793E (es) 1984-07-19
SU820659A3 (ru) 1981-04-07
FI790182A (fi) 1979-07-21
RO76393A (ro) 1981-03-30
YU5079A (en) 1983-06-30
NO151320C (no) 1985-04-17
BG31496A3 (en) 1982-01-15
NZ189378A (en) 1983-03-15
SE8603773D0 (sv) 1986-09-09
HU179793B (en) 1982-12-28
CS226181B2 (en) 1984-03-19
AR220574A1 (es) 1980-11-14
IT7947706A0 (it) 1979-01-18
ATA39879A (de) 1983-12-15
AU4337379A (en) 1979-07-26
FI71126C (fi) 1986-11-24
CH637927A5 (fr) 1983-08-31
FR2415099B1 (xx) 1981-02-20
US4294828A (en) 1981-10-13
IE790092L (en) 1979-07-20
IN150226B (xx) 1982-08-21
DE2901181A1 (de) 1979-07-26
IT1164655B (it) 1987-04-15
GR64431B (en) 1980-03-21
BE872585A (fr) 1979-06-07
NL191707C (nl) 1996-04-02
ES477782A1 (es) 1979-09-16
GB2012765A (en) 1979-08-01
AR221354A1 (es) 1981-01-30
NL191707B (nl) 1995-12-01
DK158346C (da) 1990-10-08
YU41278B (en) 1986-12-31
CA1101430A (en) 1981-05-19
GB2012765B (en) 1982-09-08
NL7900457A (nl) 1979-07-24

Similar Documents

Publication Publication Date Title
GB2012765B (en) Substituted orthoanisamides methods of preparing them compositions containing them and their application as psychotropic agents
GB2061728B (en) Stabilization of carrageenan-containing cosmetic compositions
PH15877A (en) Novel n-heterocyclyl-4-piperidiamines,pharmaceutical composition containing same and method of use
IL56646A0 (en) Agrochemical compositions comprising certain azulmic derivatives and methods of using them
JPS5562063A (en) Heterocyclic compounds*their manufacture and medical composition containing them
JPS54103450A (en) Composition and method of making same
PH18091A (en) Novel spiro-oxazolidindiones,pharmaceutical compositions containing same and method of use thereof
JPS54113608A (en) Preparation of powdered cleaning composition
CY1202A (en) Substituted heterocyclic benzamides methods of preparing them compositions containing them and their use as behaviour modifiers
JPS5513782A (en) Silicone composition and application of same
GB2031440B (en) Method of preparing aresinous pigment composition
ZW15280A1 (en) Novel substituted heterocyclic phenoxyamines the method of preparation thereof and the use thereof as local anaestheetics
JPS54135779A (en) 1*33dihydroo33*11*22*2*33dihydroo1*44benzoxinee22yl* 22hydroxyethyl*piperidinee44yl**2hhindolee22one novel derivative*its manufacture and use as drug and pharmateutical composition containing said de
GB2028819B (en) Preparation of fungicides and compositions of said fungicides
GB2030294B (en) Composition for determination of human b-microglobulin process for its preparation and its use
JPS54112933A (en) Preparation of pigment composition
JPS559089A (en) Use of arylaminobenzoic acid as hypoglycemic and composition for said use
IL58681A0 (en) Heterocyclic compounds their preparation and pharmaceutical compositions containing them
PH18500A (en) Method compounds and compositions containing them
IL58677A (en) Preparation of 1 alpha,3 beta-dihydroxy-delta 5-steroids and some such novel compounds
JPS5572133A (en) Novel 1*55dimethylbicyclo*3*2*1*octane derivatives*their manufacture and their use as perfume compound
ZA791403B (en) Composition of matter
IL57061A0 (en) Tetrahydroalstonine derivatives their preparation and parmaceutical compositions containing them
DE2961009D1 (en) Cleaning composition and its preparation and method of cleaning
IT1115001B (it) Tieno 3 2-c e 2 3-c-piridine procedimento per prepararle e composizioni terapeutiche che le contengono